New Bill could enhance UK clinical trial regulation
European Pharmaceutical Review
OCTOBER 27, 2023
This activity should bring together relevant data sets which are collected by both the Medicines and Healthcare products Regulatory Agency (MHRA) and HRA. A new sixty-day limit would be implemented for those conducting a trial to respond to Requests for Further Information (RFI) from the MHRA or Research Ethics Committees (RECs).
Let's personalize your content